FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/10/074577 [Registered on: 01/10/2024] Trial Registered Prospectively
Last Modified On: 29/09/2024
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   A study on people with schizophrenia to find and study the occurrence of obsessions and compulsive behaviour  
Scientific Title of Study   Co-occurrence of Obsessive compulsive symptoms in patients with schizophrenia and comparison of clinical profile, cognitive and socio-occupational functioning in those with and without Obsessive compulsive symptoms : a cross sectional tertiary hospital based study. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DrSujay Shenoy 
Designation  Junior Resident in department of Psychiatry 
Affiliation  KMC Manipal 
Address  Department of Psychiatry,KMC Manipal

Udupi
KARNATAKA
576104
India 
Phone  9920519657  
Fax    
Email  sujayshenoy@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Rajeshkrishna Bhandary 
Designation  Associate Professor, Department of Psychiatry 
Affiliation  KMC, Manipal 
Address  Department of Psychiatry,KMC Manipal

Udupi
KARNATAKA
576104
India 
Phone  9844542567  
Fax    
Email  rajesh.kbp@manipal.edu  
 
Details of Contact Person
Public Query
 
Name  Dr Rajeshkrishna Bhandary 
Designation  Associate Professor, Department of Psychiatry 
Affiliation  KMC, Manipal 
Address  Department of Psychiatry,KMC Manipal

Udupi
KARNATAKA
576104
India 
Phone  9844542567  
Fax    
Email  rajesh.kbp@manipal.edu  
 
Source of Monetary or Material Support  
Department of Psychiatry Kasturba Medical College, Manipal Udupi -576104 
 
Primary Sponsor  
Name  PG Research Fund, KMC 
Address  Dean office, Kasturba Medical College, Manipal 
Type of Sponsor  Private hospital/clinic 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sujay Shenoy  Kasturba Hospital,Manipal  Department of Psychiatry, Kasturba Hospital, Manipal,Udupi, Karnataka
Udupi
KARNATAKA 
9920519657

sujayshenoy@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Kasturba Medical College and Kasturba Hospital Institutional Ethics Committee - 2 (student research)  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: F20||Schizophrenia,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
Comparator Agent  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1) Diagnosis of schizophrenia (according to DSM-5)
2) Age group : 18 – 60 years
3) Patients consenting to take part in the study
4) Who are able to understand English/ Kannada and identify English numbers
 
 
ExclusionCriteria 
Details  1) Presence of comorbid neurological condition like stroke, epilepsy, degenerative diseases, Movement disorder etc.
2) Uncontrolled chronic medical conditions like hypertension, diabetes, hypothyroidism
3) Intellectual disability
4) Presence of substance use – except nicotine
5) Comorbid other psychiatry conditions such as Mood Disorder, Personality disorder.
6) History of head injury
7) Autoimmune conditions
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
a)Presence of OC symptoms/OCD in patients with schizophrenia.
b)Sociodemographic and clinical variables associated with OC symptoms in Schizophrenia.
c)To compare socio-occupational functioning in people having schizophrenia with and without OCD or OC symptoms.
d)Based on study conducted by Punya Mulky et al.2015 having a sample size of 100 and prevalence of 28%, the sample size estimated for study is 89.
 
At a single time point.Will be assessed at end of the study 
 
Secondary Outcome  
Outcome  TimePoints 
Association of antipsychotic used with OC symptoms   At a single time point.Will be assessed at end of the study 
 
Target Sample Size   Total Sample Size="89"
Sample Size from India="89" 
Final Enrollment numbers achieved (Total)= "89"
Final Enrollment numbers achieved (India)="89" 
Phase of Trial   N/A 
Date of First Enrollment (India)   10/10/2024 
Date of Study Completion (India) 20/03/2026 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Completed 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Patients with diagnosis of Schizophrenia will be recruited in to the study. They will be screened for inclusion exclusion  criteria using DIAMOND screen. 
Following rating scales will be administered - BPRS, YBOCS, BCATS and SOFS. 
OC symptoms will be graded for meeting or not meeting diagnostic criteria. 
Analysis will be done using SPSS software. 
 
Close